NCT03264261

Brief Summary

To compare the effect of constraint induced movement therapy (CIMT) vs. treadmill training only on walking function in individuals post-stroke, a 6 week, single-blind, randomized training study will be conducted with three assessments of gait to determine the training effect. Subjects will be randomized to either the CIMT or treadmill training only groups at the initial test. Following the initial test, individuals from the 2 groups will undergo intensive locomotor training. Training will be performed 3 times per week for 6 weeks with the training time for each visit set to 45 minutes as tolerated. Data collection will proceed until 36 subjects from 2 groups have been trained.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
36

participants targeted

Target at P25-P50 for not_applicable stroke

Timeline
Completed

Started Aug 2017

Longer than P75 for not_applicable stroke

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 14, 2017

Completed
Same day until next milestone

Study Start

First participant enrolled

August 14, 2017

Completed
15 days until next milestone

First Posted

Study publicly available on registry

August 29, 2017

Completed
7.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 30, 2025

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2025

Completed
Last Updated

June 3, 2025

Status Verified

May 1, 2025

Enrollment Period

8 years

First QC Date

August 14, 2017

Last Update Submit

May 28, 2025

Conditions

Keywords

stroke, locomotion

Outcome Measures

Primary Outcomes (2)

  • Change in walking speed

    Overground gait speed will be collected on a 10 m instrumented walkway

    pre, post 6 weeks training, and 8 weeks after the end of training.

  • Change in 6-minute walking distance

    walking distance covered by subjects in 6 minutes

    pre, post 6 weeks training, and 8 weeks after the end of training.

Secondary Outcomes (1)

  • Change in Berg Balance Scale

    pre, post 6 weeks training, and 8 weeks after the end of training.

Study Arms (2)

robotic training

EXPERIMENTAL

For the robotic training group, a controlled resistance load will be applied to the unaffected leg at the ankle and an assistance load will be applied to the pelvis.

Device: robotic training

treadmill training

ACTIVE COMPARATOR

For the treadmill training only group, a physical therapist will provide manual assistance to the affected leg at the knee and/or ankle joints as necessary during treadmill training.

Device: treadmill training

Interventions

robotic training, 3 times/week for 6 weeks

robotic training

treadmill training only, 3 times/week for 6 weeks

treadmill training

Eligibility Criteria

Age21 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • age between 21 and 75 years;
  • history of unilateral, supratentorial, ischemic or hemorrhagic stroke;
  • no prior stroke;
  • demonstration of impaired walking function (self-selected walking speed ≤ 0.80 m/s);
  • able to stand and walk (\>10 meters) without physical assistance.

You may not qualify if:

  • significant cardiorespiratory/metabolic disease;
  • other neurological or orthopedic injury that impairs locomotion;
  • scores on the Mini Mental Status examination \< 24;
  • stroke of the brainstem or cerebellar lesions;
  • uncontrolled hypertension (systolic \> 200 mm Hg, diastolic \> 110 mm Hg);
  • botox injection within 6 months of starting the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Abilitylab

Chicago, Illinois, 60611, United States

RECRUITING

MeSH Terms

Conditions

Stroke

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Study Officials

  • Ming Wu, PhD

    Abilitylab

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Weena Dee, PT

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Outcome measures of each subject will be evaluated before training, after 6 weeks of training, and at 8 weeks after the end of training by a physical therapist who is blinded by subject group assignment, and subjects will be requested not to disclose his/her group assignment to this physical therapist.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Subjects will be blocked by gait speed into slow (\< 0.4 m/s) or fast (≥ 0.4 m/s) subgroups and randomized to either the CIMT or treadmill training only groups at the initial test.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Research Scientist

Study Record Dates

First Submitted

August 14, 2017

First Posted

August 29, 2017

Study Start

August 14, 2017

Primary Completion

July 30, 2025

Study Completion

December 30, 2025

Last Updated

June 3, 2025

Record last verified: 2025-05

Data Sharing

IPD Sharing
Will not share

Locations